lonidamine has been researched along with Leukemia P388 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Konovalova, NP | 1 |
| Caputo, A; Silvestrini, B | 1 |
| Adwankar, MK; Chitnis, MP | 1 |
| Adwankar, M; Chitnis, M | 1 |
1 review(s) available for lonidamine and Leukemia P388
| Article | Year |
|---|---|
Lonidamine, a new approach to cancer therapy.
Topics: Abnormalities, Drug-Induced; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Division; Diuresis; Female; Indazoles; Kidney; Leukemia P388; Lung Neoplasms; Male; Mitochondria; Oxygen Consumption; Pregnancy; Pyrazoles; Sarcoma 180; Spermatogenesis | 1984 |
3 other study(ies) available for lonidamine and Leukemia P388
| Article | Year |
|---|---|
Ultralow doses of various drugs in chemotherapy of experimental tumors.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Indazoles; Leukemia P388; Lung Neoplasms; Melanoma; Mice; Mitomycin; Neoplasm Metastasis; Neoplasms, Experimental; Triazoles; Xenograft Model Antitumor Assays | 2003 |
Modification of tumor cell sensitivity to antineoplastic agents lonidamine and bouvardin (NSC 259968) at elevated temperatures.
Topics: Animals; Antineoplastic Agents; DNA; Drug Resistance; Hyperthermia, Induced; Indazoles; Leukemia P388; Mice; Neoplasms, Experimental; Peptides, Cyclic; Pyrazoles; Sarcoma 180; Thymidine; Tritium | 1986 |
Potentiation of adriamycin cytotoxicity in P388 murine leukemia sensitive and resistant to adriamycin by use of lonidamine and hyperthermia.
Topics: Animals; Doxorubicin; Drug Resistance; Drug Synergism; Hyperthermia, Induced; Indazoles; Leukemia P388; Leukemia, Experimental; Mice; Pyrazoles; Time Factors | 1986 |